Drug intelligence / Profile preview

Jianjining

Development stage: Unknown
Administration: Oral

Overview

Jianjining (健肌宁) is a drug product from China. Based on available information, it is marketed under the brand name "Jianjining" and is used in clinical practice in China. However, there is no detailed information available in the provided search results or major international drug databases regarding its active ingredient(s), mechanism of action, developer, or specific indications. The name suggests it may be related to muscle health ("健肌" translates as "muscle health/strengthening"), but this cannot be confirmed without further data.

Brand names: Jianjining健肌宁
Other names: 健肌宁

Beyond the preview

Go deeper on Jianjining.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jianjining.

Explore the full profile